2024-03-27
Reviva to Present RECOVER Phase 3 Clinical Trial Data for Brilaroxazine in Schizophrenia at the ASCPT 2024 Annual Meeting
临床3期孤儿药临床结果
2024-03-27
Opus Genetics Announces Completion of Dosing in First Cohort of Phase 1/2 Trial of Gene Therapy OPGx-LCA5 in Patients with Rare Inherited Retinal Disease LCA5
基因疗法临床研究
2024-03-27
并购抗体药物偶联物
2024-03-27
Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection
临床2期免疫疗法
2024-03-27
NKGen Biotech Presents Additional Phase 1 Clinical Trial Data in Alzheimer’s Disease at the Tau2024 Global Conference
细胞疗法临床结果
2024-03-27
全球首批!首个CLDN18.2单抗获批上市,一线治疗胃癌
临床结果上市批准临床成功
2024-03-27
并购突破性疗法优先审批申请上市
2024-03-26
Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation
临床结果财报
2024-03-26
Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome
上市批准并购优先审批孤儿药
2024-03-26
引进/卖出基因疗法